Post by
Breakthorough1 on Aug 14, 2023 10:26am
17 March 2021
"Based on these results, IMV recently engaged with the FDA which provided productive feedback. The Company is working with Merck to finalize the protocol of the Phase 2b clinical study which is expected to begin in Q2 2021."
But the trial only begun in 2022.